Investment Rating - The report maintains a "Buy" rating for H&H International Holdings (01112.HK) [1] Core Views - The management is actively pursuing growth strategies, and the company is expected to enter a new growth cycle driven by product innovation and market expansion [7] - The company has shown resilience with a strong recovery in profitability, with a projected net profit of 276.77 million in 2025, a significant turnaround from a loss in 2024 [7] - The report highlights the anticipated strong growth in the BNC and infant formula segments, with expected revenue growth rates of 20-30% for infant formula and low single-digit growth for probiotics and nutritional products [7] Financial Projections - Total revenue is projected to reach 14,447 million in 2025, with a year-on-year growth of 10.69% [1] - The adjusted net profit is expected to grow significantly, with projections of 276.77 million in 2025, 637.48 million in 2026, and 882.11 million in 2027, reflecting growth rates of 615.21% and 130.33% respectively [7] - The report anticipates a gradual improvement in the company's financial metrics, including an EBITDA increase to 2,077.71 million by 2027 [8]
H&H国际控股（01112）：H、H国际控股（01112）：β与α共振，管理层积极进取，维持重点推荐